home / stock / unh / unh articles


UNH Articles, UnitedHealth Group Incorporated - From 06/13/24

Stock Information

Company Name: UnitedHealth Group Incorporated
Stock Symbol: UNH
Market: NYSE
Website: unitedhealthgroup.com

Menu

UNH UNH Quote UNH Short UNH News UNH Articles UNH Message Board
Get UNH Alerts

News, Short Squeeze, Breakout and More Instantly...

ROSEN, A LONGSTANDING LAW FIRM, Encourages UnitedHealth Group Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – UNH | Benzinga

NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Unit...

UNH Investors Have Opportunity to Lead UnitedHealth Group Securities Fraud Lawsuit with the Schall Law Firm | Benzinga

LOS ANGELES, June 12, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class ...

Industry Comparison: Evaluating UnitedHealth Group Against Competitors In Health Care Providers & Services Industry | Benzinga

In the dynamic and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this artic...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UnitedHealth, Vestis, Teladoc, and Cambium and Encourages Investors to Contact the Firm | Benzinga

NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds invest...

UnitedHealth Group Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm | Benzinga

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 07, 2024 (GLOBE NEWSWIRE) -- The Por...

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 15, 2024 in UnitedHealth Lawsuit – UNH | Benzinga

NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in UnitedHealth Group Inc. ("UnitedHealth" or t...

AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability | Benzinga

AbbVie Inc’s (NYSE:ABBV) top-selling arthritis drug, Humira, has managed to retain over 80% of its patients even after facing nine lower-pric...

Class Action Filed Against UnitedHealth Group Inc. (UNH) Seeking Recovery for Investors – Contact The Gross Law Firm | Benzinga

NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of UnitedHealth Group Inc. (NYSE:UNH)...

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages UnitedHealth Group Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – UNH | Benzinga

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Unit...

Post UnitedHealth Cyberattack, Community Health Centers Face Prolonged Disruption | Benzinga

More than three months after a cyberattack on UnitedHealth Group Inc’s (NYSE:UNH) technology unit, community health centers serving 30 millio...

Previous 10 Next 10